Insulin Pump Market (By Pump Type: Tethered Pump and Patch Pump; By Accessories: Battery, Insulin Set Insertion Devices, and Insulin Reservoir; By End User: Hospitals, Clinics, Homecare, and Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021 – 2030

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Insulin Pump Market 

5.1. COVID-19 Landscape: Insulin Pump Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Insulin Pump Market, By Pump

8.1. Insulin Pump Market, by Pump Type, 2021-2030

8.1.1. Tethered Pump

8.1.1.1. Market Revenue and Forecast (2019-2030)

8.1.2. Patch Pump

8.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 9. Global Insulin Pump Market, By Application

9.1. Insulin Pump Market, by Application, 2021-2030

9.1.1. Battery

9.1.1.1. Market Revenue and Forecast (2019-2030)

9.1.2. Insulin Set Insertion Devices

9.1.2.1. Market Revenue and Forecast (2019-2030)

9.1.3. Insulin Reservoir

9.1.3.1. Market Revenue and Forecast (2019-2030)

Chapter 10. Global Insulin Pump Market, By Disease Indication Type 

10.1. Insulin Pump Market, by Disease Indication Type, 2021-2030

10.1.1. Type 1 Diabetes

10.1.1.1. Market Revenue and Forecast (2019-2030)

10.1.2. Type 2 Diabetes

10.1.2.1. Market Revenue and Forecast (2019-2030)

Chapter 11. Global Insulin Pump Market, By End User Type 

11.1. Insulin Pump Market, by End User Type, 2021-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2019-2030)

11.1.2. Clinics

11.1.2.1. Market Revenue and Forecast (2019-2030)

11.1.3. Homecare

11.1.3.1. Market Revenue and Forecast (2019-2030)

11.1.4. Laboratories

11.1.4.1. Market Revenue and Forecast (2019-2030)

Chapter 12. Global Insulin Pump Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Pump (2019-2030)

12.1.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.1.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.1.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.1.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.1.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.1.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.1.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.7.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Pump (2019-2030)

12.2.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.2.8.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.2.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.7.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Pump (2019-2030)

12.3.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.3.8.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.3.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.7.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.7.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.7.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Pump (2019-2030)

12.4.8.2. Market Revenue and Forecast, by Application (2019-2030)

12.4.8.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.4.8.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Pump (2019-2030)

12.5.5.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.5.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.5.5.4. Market Revenue and Forecast, by End User Type (2019-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Pump (2019-2030)

12.5.6.2. Market Revenue and Forecast, by Application (2019-2030)

12.5.6.3. Market Revenue and Forecast, by Disease Indication Type (2019-2030)

12.5.6.4. Market Revenue and Forecast, by End User Type (2019-2030)

Chapter 13. Company Profiles

13.1. Medtronic Plc

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Insulet Corporation

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Medzer

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Microport Scientific

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Eoflow

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Debiotech S.A.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Lenomed Medical

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Microtech Medical

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cequr SA

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. F. Hoffmann La Roche AG

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

13.11. Ypsomed AG

13.11.1. Company Overview

13.11.2. Product Offerings

13.11.3. Financial Performance

13.11.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

PROCEED TO BUY

   USD 4900.00
   USD 7000
   USD 9000

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample